Entegris CapEx decreased by 28.4% to $41.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 61.6%, from $108.00M to $41.50M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 9.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.77M | $48.89M | $76.64M | $84.41M | $107.69M | $126.74M | $147.36M | $133.99M | $116.05M | $78.14M | $128.62M | $66.60M | $59.30M | $82.20M | $107.50M | $108.00M | $66.50M | $66.70M | $58.00M | $41.50M |
| QoQ Change | — | +17.0% | +56.8% | +10.1% | +27.6% | +17.7% | +16.3% | -9.1% | -13.4% | -32.7% | +64.6% | -48.2% | -11.0% | +38.6% | +30.8% | +0.5% | -38.4% | +0.3% | -13.0% | -28.4% |
| YoY Change | — | — | — | — | +157.8% | +159.3% | +92.3% | +58.7% | +7.8% | -38.3% | -12.7% | -50.3% | -48.9% | +5.2% | -16.4% | +62.2% | +12.1% | -18.9% | -46.0% | -61.6% |